This report describes essential requirements for the validation of a radioimmunoassay (RIA) 
INTRODUCTION
Increasing interest in the physiological role of insulin¬ like growth factor-I (IGF-I) in vivo has led to a prolifer¬ ation of immunoassay systems for the measurement of plasma IGF-I. Many of these systems, however, have not been rigorously validated, and a number of poten¬ tial pitfalls are apparent which limit the value of some data obtained.
A rapidly increasing number of recombinant human IGF-I (rhIGF-I) preparations have been used for radioimmunoassays (RIAs), some of which contain variants with mismatched disulphide linkages and reveal significant heterogeneity (Buell, Schulz, Selzer etal. 1985; Meng, Burleigh& Kelly, 1988) . This hetero¬ geneity appears to be particularly common when rhIGF-I has been produced by bacterial as opposed to yeast fermentation. Two major peaks may be seen on analytical high-pressure liquid chromatography (HPLC) representing intact and misfolded IGF-I (Meng et al. 1988) , which differ in biological potency and their ability to bind IGF-binding proteins (IGFBPs) (Hodgkinson, Napier, Davis et al. 1989Z>) . The potential problems caused by such heterogeneous materials in assay systems have not been considered.
It is now appreciated that dissociation and removal of IGFBPs from circulating IGF-I is essential before plasma samples can be reliably assayed (Daughaday, Kapadia & Mariz, 1987) . Acidification of plasma and separation of free IGF-I by column chromatography under acidic conditions has been generally accepted as the most reliable approach (Daughaday & Rotwein, 1989) and is regarded as the standard method. The expensive and laborious nature of this method, how¬ ever, makes it unsuitable for routine assays. With the need for high-volume assays the acid-ethanol extrac¬ tion (AE), as originally developed for post-natal human plasma (Daughaday, Mariz & Blethen, 1980) , has been widely used during recent years. However, its use has been extended to fluids other than plasma and species other than man. Such use has often not been subject to rigorous validation. It is therefore not surpris¬ ing that there is persisting uncertainty over the validity of some IGF-I RIA systems (Daughaday et al. 1987; Mesiano, Young, Browne & Thorburn, 1988) .
In this paper we illustrate problems that may arise from the inappropriate selection of IGF-I preparations and the incomplete validation of an RIA for IGF-I on extracted plasma. We demonstrate the need to evaluate extraction systems across a range of samples in which the ratio of IGF-I to IGFBP can be anticipated to vary markedly. Furthermore, we present data show¬ ing that the commonly used AE extraction technique (Daughaday et al. 1980 ) is unsatisfactory for plasma samples obtained under extreme physiological con¬ ditions. We describe a modified AE extraction method which includes a cryo-precipitation step (AEC). This AEC extraction has validity over a wide range of different IGFBP profiles encountered in blood plasma from a variety of species including sheep, rat, mouse and man.
MATERIALS AND METHODS

Materials
Recombinant hIGF-I produced by bacterial fermen¬ tation (rh-met-IGF-I) batch 742.44 and HPLC-purified misfolded rh-met-IGF-I (misfolded IGF-I) (Meng et al. 1988) (Butler & Gluckman, 1986) (pH 7-2) and the samples were eluted with the same buffer at a flow rate of 0-5 ml/min. Fractions of 0-25 ml were collected after an 8-min delay and the radioactivity in the eluate was determined in a gamma counter. The Superóse 12 column was calibrated before use with a range of Mr markers.
RIA of IGF-I
The y-rhIGF-I was iodinated by a modified chloramine method (Gluckman, Johnson-Barrett, Butler et al. 1983 ). The 125I-labelled y-rhIGF-I was purified by exclusion chromatography on a prealbuminated Sephadex G-50 (Pharmacia) column (10 mm 600 mm). Fractions of 40 drops were collected using (Snedecor & Cochran, 1989 (Fig. 1) (Fig. 2) . The data illustrated in Fig. 2 (Fig. 4) Fig. 5a ). There was no significant correlation for fetal sheep samples when 50 pi of extract was used (Fig. 5b) Extracted samples were analysed at a twofold difference in concentration ( 100 µ and 50 µ extract). The correlation coefficient (r), the intercept (a) and the slope (b) of the regression were calculated on IGF-I values obtained in the assay after either extraction technique of the same plasma samples. The probability (P) (Buell et al. 1985; Meng et al. 1988) . Frequent contaminants in recombinantderived materials are misfolded forms (Meng et al. 1988 ) although other variants have also been reported (Ballard, Francis, Ross et al. 1987; Gellersfors, Axelsson, Helander et al. 1989 ). These IGF-I variants show markedly reduced ability to bind to IGFBPs (Hodgkinson et al. 19860) (Breier, Gallaher, Gibson et al. 1990 ).
